Dana-Farber/New Hampshire Oncology-Hematology

Londonderry, New Hampshire 03053

2 studies enrolling now · 14 studies all time

What they study most

B-cell Malignancy, Low-grade, Blood Clot, Breast Cancer, Breast Neoplasms, Cancer, Deep Vein Thrombosis (DVT), Early Stage Breast Cancer, Hematological Malignancies, IgG Monoclonal Gammopathy of Uncertain Significance, Metastatic Breast Cancer, Metastatic Colorectal Cancer, Metastatic Prostate Cancer

Studies at this site

• The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study — Recruiting now
• Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome — Recruiting now
• ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer — Running, not enrolling
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
• The Young Women's Breast Cancer Study — Running, not enrolling
• Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer — Stopped early
• Palbociclib After CDK and Endocrine Therapy (PACE) — Running, not enrolling
• Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer — Running, not enrolling
• Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer — Completed
• Eribulin in HER2 Negative Metastatic BrCa — Completed
• Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers — Completed
• Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer — Completed
• Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer — Completed
• Study of Vitamin D in Untreated Metastatic Colorectal Cancer — Completed